| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5931793 | The American Journal of the Medical Sciences | 2015 | 6 Pages |
Abstract
No difference in clinical or microbiologic cure rates was observed between groups. Daptomycin and vancomycin appear equally efficacious for MRSA bacteremia, whereas linezolid therapy was associated with higher mortality.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Justin B. PharmD, Ngan H. PharmD, Christopher K. PharmD, Kerry O. MD, Michael S. MD, Timothy H PharmD,